Nalbuphine extended release (ER) significantly reduces cough frequency and severity in patients with idiopathic pulmonary fibrosis (IPF), especially at higher doses, compared with placebo. The trial ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Even a disease as deadly as idiopathic pulmonary fibrosis (IPF) can start out as just a cough. But as the condition progresses, a person might experience up to 500 respiratory spasms per day.

Dublin, March 28, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Idiopathic Pulmonary Fibrosis (IPF) Pipeline Analysis, 2016" report to their offering. The IPF ...

SAN DIEGO -- Two novel drugs improved lung function in idiopathic pulmonary fibrosis (IPF) in a pair of phase IIa trials, researchers reported here. In an open-label, single-arm trial of 46 patients ...

Pulmonary fibrosis and emphysema are two lung conditions that have some symptoms in common. These include a cough, shortness of breath, tiredness, and swelling in the legs. In addition to having ...

Key Points Interested in Contineum Therapeutics, Inc.? Here are five stocks we like better. Contineum remains focused on PIPE ...

(MENAFN- GlobeNewsWire - Nasdaq) Company announces $30 million Series A financing and founding leadership team with expertise in pulmonary drug innovation and track record advancing novel therapies to ...